New Technology Enhances And Expands “Homing”and Therapeutic Potential Of Cord Blood Stem Cells In Bone Marrow Transplants

A CD26 Inhibitor increases the efficiency and responsiveness of umbilical cord blood for bone marrow transplants and may improve care for blood cancer patients according to research from Rush University Medical Center being presented at the 6th Annual International Umbilical Cord Blood Transplantation Symposium, June 6-7 in Los Angeles. Kent W.

More: continued here

Filed under: Lymphoma / Leukemia on June 10th, 2008